Breaking News Instant updates and real-time market news.

GRTX

Galera Therapeutics

$12.44 /

+0.64 (+5.42%)

17:03
10/23/20
10/23
17:03
10/23/20
17:03

Galera reports 'positive' interim data from first patient cohort in GC4419 trial

Galera Therapeutics announced the release of the abstract containing interim data from the first 19 patients in its pilot Phase 1/2 clinical trial designed to evaluate the safety and efficacy of avasopasem manganese in combination with stereotactic body radiation therapy, compared with SBRT and placebo, in patients with locally advanced pancreatic cancer. The interim data were shared in abstract #LBA5 on the 2020 American Society for Radiation Oncology Annual Meeting virtual program website. Galera's investigational, highly selective small molecule superoxide dismutase (SOD) mimetics are designed to rapidly and selectively convert superoxide to hydrogen peroxide and oxygen. These dismutase mimetics have potential anti-cancer synergy based on positive results in multiple preclinical models. In the initial analysis of the intent-to-treat cohort enrolled in the first, single-center stage of the trial, which comprises all patients followed for over a year, median overall survival had not yet been reached in the GC4419 arm, compared to 40.4 weeks in the placebo arm. The GC4419 arm also demonstrated favorable progression-free survival, locoregional control and time-to-distant metastases compared to the placebo arm. The incidence of acute or late Grade 3+ toxicity post-SBRT was similar in both arms.

  • 07

    Nov

GRTX Galera Therapeutics
$12.44 /

+0.64 (+5.42%)

10/02/20 Citi
Citi opens 'positive catalyst watch' on Galera Therapeutics
12/02/19 BTIG
Galera Therapeutics initiated with a Buy at BTIG
12/02/19 Credit Suisse
Galera Therapeutics initiated with a Neutral at Credit Suisse
12/02/19 Citi
Galera Therapeutics initiated with a Buy at Citi

TODAY'S FREE FLY STORIES

Hot Stocks
HP Inc. raises quarterly dividend 10% to 19.38c from 17.62c per share » 18:20
11/24/20
11/24
18:20
11/24/20
18:20
HPQ

HP Inc.

$21.78 /

+0.59 (+2.78%)

The HP Inc. board of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HPQ HP Inc.
$21.78 /

+0.59 (+2.78%)

HPQ HP Inc.
$21.78 /

+0.59 (+2.78%)

10/13/20 Morgan Stanley
Morgan Stanley upgrades IT Hardware industry view to Attractive from In-Line
09/22/20 UBS
HP Inc. assumed with a Buy from Neutral at UBS
09/08/20 Standpoint Research
HP Inc. upgraded to Buy from Hold at Standpoint Research
08/28/20 Loop Capital
HP Inc. price target raised to $25 from $20 at Loop Capital
HPQ HP Inc.
$21.78 /

+0.59 (+2.78%)

HPQ HP Inc.
$21.78 /

+0.59 (+2.78%)

HPQ HP Inc.
$21.78 /

+0.59 (+2.78%)

HPQ HP Inc.
$21.78 /

+0.59 (+2.78%)

Earnings
Dell Technologies sees Q4 revenue up 3%-4% sequentially, consensus $23.09B » 18:13
11/24/20
11/24
18:13
11/24/20
18:13
DELL

Dell Technologies

$70.37 /

+0.9701 (+1.40%)

Sees Q4 PC business…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DELL Dell Technologies
$70.37 /

+0.9701 (+1.40%)

DELL Dell Technologies
$70.37 /

+0.9701 (+1.40%)

10/15/20 JPMorgan
Dell Technologies price target raised to $80 from $70 at JPMorgan
10/13/20 UBS
VMware initiated with a Neutral at UBS
10/13/20 Morgan Stanley
Morgan Stanley upgrades IT Hardware industry view to Attractive from In-Line
09/22/20 UBS
Dell Technologies assumed with a Buy from Neutral at UBS
DELL Dell Technologies
$70.37 /

+0.9701 (+1.40%)

DELL Dell Technologies
$70.37 /

+0.9701 (+1.40%)

DELL Dell Technologies
$70.37 /

+0.9701 (+1.40%)

DELL Dell Technologies
$70.37 /

+0.9701 (+1.40%)

Hot Stocks
Nautilus VP Collins sells almost 6K shares of company stock » 17:55
11/24/20
11/24
17:55
11/24/20
17:55
NLS

Nautilus

$17.80 /

-0.56 (-3.05%)

Nautilus VP Jeffrey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NLS Nautilus
$17.80 /

-0.56 (-3.05%)

NLS Nautilus
$17.80 /

-0.56 (-3.05%)

11/10/20 Lake Street
Nautilus price target raised to $40 from $30 at Lake Street
11/10/20 Craig-Hallum
Nautilus price target raised to $28 from $22 at Craig-Hallum
10/15/20 Lake Street
Nautilus price target raised to $30 from $17 at Lake Street
10/14/20 Truist
Nautilus price target raised to $28 from $18 at Truist
NLS Nautilus
$17.80 /

-0.56 (-3.05%)

NLS Nautilus
$17.80 /

-0.56 (-3.05%)

NLS Nautilus
$17.80 /

-0.56 (-3.05%)

NLS Nautilus
$17.80 /

-0.56 (-3.05%)

Conference/Events
Goldman Sachs economists to hold analyst/industry conference call » 17:51
11/24/20
11/24
17:51
11/24/20
17:51

Chief Asia Economist…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Tiger Global led $131M in Series C funding for U.S. 'challenger bank' Current » 17:51
11/24/20
11/24
17:51
11/24/20
17:51
GS

Goldman Sachs

$237.86 /

+9.03 (+3.95%)

, PYPL

PayPal

$206.00 /

+5.08 (+2.53%)

, SQ

Square

$202.90 /

-4.89 (-2.35%)

, ALLY

Ally Financial

$31.07 /

+1.215 (+4.07%)

, COF

Capital One

$91.36 /

+4.07 (+4.66%)

, DFS

Discover

$81.56 /

+3.35 (+4.28%)

Mobile banking app…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GS Goldman Sachs
$237.86 /

+9.03 (+3.95%)

PYPL PayPal
$206.00 /

+5.08 (+2.53%)

SQ Square
$202.90 /

-4.89 (-2.35%)

ALLY Ally Financial
$31.07 /

+1.215 (+4.07%)

COF Capital One
$91.36 /

+4.07 (+4.66%)

DFS Discover
$81.56 /

+3.35 (+4.28%)

GS Goldman Sachs
$237.86 /

+9.03 (+3.95%)

10/19/20 Credit Suisse
Goldman Sachs price target raised to $262 from $255 at Credit Suisse
10/15/20 BMO Capital
Goldman Sachs price target raised to $274 from $267 at BMO Capital
10/15/20 Oppenheimer
Goldman Sachs price target raised to $356 from $326 at Oppenheimer
10/15/20 Barclays
Goldman Sachs price target raised to $270 from $253 at Barclays
PYPL PayPal
$206.00 /

+5.08 (+2.53%)

11/19/20 Morgan Stanley
Growth of Square's Cash App may be impacted by needed fixes, says Morgan Stanley
11/19/20 Keefe Bruyette
Too early to know if new Google Pay is PayPal, Square threat, says KBW
11/10/20 Mizuho
PayPal price target lowered to $270 from $290 at Mizuho
11/05/20 DZ Bank
PayPal upgraded to Buy from Hold at DZ Bank
SQ Square
$202.90 /

-4.89 (-2.35%)

11/19/20 Morgan Stanley
Growth of Square's Cash App may be impacted by needed fixes, says Morgan Stanley
11/19/20 Keefe Bruyette
Too early to know if new Google Pay is PayPal, Square threat, says KBW
11/19/20 Mizuho
Square price target raised to $300 from $225 at Mizuho
11/16/20 KeyBanc
Square price target raised to $250 from $215 at KeyBanc
ALLY Ally Financial
$31.07 /

+1.215 (+4.07%)

10/19/20 BMO Capital
Ally Financial price target raised to $36 from $34 at BMO Capital
10/09/20 JPMorgan
Ally Financial price target raised to $30 from $23.50 at JPMorgan
09/23/20 Piper Sandler
Ally Financial price target raised to $31 from $27 at Piper Sandler
08/24/20 Stephens
Stephens would be long Ally Financial into CFO presentation at conference
COF Capital One
$91.36 /

+4.07 (+4.66%)

11/18/20 Compass Point
Capital One price target raised to $102 from $78 at Compass Point
11/12/20 Piper Sandler
Capital One price target raised to $105 from $93 at Piper Sandler
10/26/20 BMO Capital
Capital One price target raised to $133 from $127 at BMO Capital
10/26/20 Deutsche Bank
Capital One price target raised to $83 from $73 at Deutsche Bank
DFS Discover
$81.56 /

+3.35 (+4.28%)

11/17/20 Piper Sandler
Discover price target raised to $80 from $70 at Piper Sandler
10/23/20 BMO Capital
Discover price target raised to $80 from $76 at BMO Capital
10/23/20 RBC Capital
Discover price target raised to $75 from $61 at RBC Capital
10/23/20 Deutsche Bank
Discover price target raised to $74 from $55 at Deutsche Bank
GS Goldman Sachs
$237.86 /

+9.03 (+3.95%)

PYPL PayPal
$206.00 /

+5.08 (+2.53%)

SQ Square
$202.90 /

-4.89 (-2.35%)

ALLY Ally Financial
$31.07 /

+1.215 (+4.07%)

COF Capital One
$91.36 /

+4.07 (+4.66%)

DFS Discover
$81.56 /

+3.35 (+4.28%)

GS Goldman Sachs
$237.86 /

+9.03 (+3.95%)

PYPL PayPal
$206.00 /

+5.08 (+2.53%)

SQ Square
$202.90 /

-4.89 (-2.35%)

COF Capital One
$91.36 /

+4.07 (+4.66%)

DFS Discover
$81.56 /

+3.35 (+4.28%)

GS Goldman Sachs
$237.86 /

+9.03 (+3.95%)

PYPL PayPal
$206.00 /

+5.08 (+2.53%)

SQ Square
$202.90 /

-4.89 (-2.35%)

ALLY Ally Financial
$31.07 /

+1.215 (+4.07%)

COF Capital One
$91.36 /

+4.07 (+4.66%)

DFS Discover
$81.56 /

+3.35 (+4.28%)

GS Goldman Sachs
$237.86 /

+9.03 (+3.95%)

PYPL PayPal
$206.00 /

+5.08 (+2.53%)

SQ Square
$202.90 /

-4.89 (-2.35%)

ALLY Ally Financial
$31.07 /

+1.215 (+4.07%)

COF Capital One
$91.36 /

+4.07 (+4.66%)

DFS Discover
$81.56 /

+3.35 (+4.28%)

Conference/Events
Goldman Sachs to hold global macro equity monthly conference call » 17:47
11/24/20
11/24
17:47
11/24/20
17:47

Senior Markets Advisor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Siris Capital lowers its stake in Plantronics to 4.8% from 7.5% » 17:31
11/24/20
11/24
17:31
11/24/20
17:31
PLT

Plantronics

$26.39 /

+0.9 (+3.53%)

Siris Capital disclosed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLT Plantronics
$26.39 /

+0.9 (+3.53%)

PLT Plantronics
$26.39 /

+0.9 (+3.53%)

11/02/20 JPMorgan
Plantronics upgraded on sustainable demand spike at JPMorgan
11/02/20 JPMorgan
Plantronics upgraded to Overweight from Neutral at JPMorgan
10/12/20 Northland
Plantronics upgraded to Outperform from Market Perform at Northland
09/15/20
Fly Intel: Top five analyst upgrades
PLT Plantronics
$26.39 /

+0.9 (+3.53%)

  • 28
    Aug
PLT Plantronics
$26.39 /

+0.9 (+3.53%)

Conference/Events
UBS sustainability/ESG analysts hold an analyst/industry conference call » 17:28
11/24/20
11/24
17:28
11/24/20
17:28

Sustainability and ESG…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Triton International CFO sells 20K shares of common stock » 17:28
11/24/20
11/24
17:28
11/24/20
17:28
TRTN

Triton International

$45.83 /

-0.24 (-0.52%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRTN Triton International
$45.83 /

-0.24 (-0.52%)

TRTN Triton International
$45.83 /

-0.24 (-0.52%)

10/26/20 CJS Securities
Triton International upgraded to Outperform from Market Perform at CJS Securities
07/24/20 BofA
Triton International double upgraded to Buy from Underperform at BofA
07/24/20 BofA
Triton International upgraded to Buy from Underperform at BofA
12/16/19 William Blair
CAI International worth at least $33 per share, says William Blair
TRTN Triton International
$45.83 /

-0.24 (-0.52%)

  • 01
    Oct
Conference/Events
UBS leisure/lodging analyst holds an analyst/industry conference call » 17:26
11/24/20
11/24
17:26
11/24/20
17:26

Leisure & Lodging…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Gap drops 10% to $24.06 after Q3 earnings miss  17:24
11/24/20
11/24
17:24
11/24/20
17:24
GPS

Gap

$26.87 /

+0.81 (+3.11%)

 
ShowHide Related Items >><<
GPS Gap
$26.87 /

+0.81 (+3.11%)

GPS Gap
$26.87 /

+0.81 (+3.11%)

11/23/20
Fly Intel: Top five analyst upgrades
11/23/20 Morgan Stanley
Gap price target raised to $25 from $22 at Morgan Stanley
11/23/20 JPMorgan
Gap upgraded to Overweight with $30 price target at JPMorgan
11/23/20 JPMorgan
Gap upgraded to Overweight from Neutral at JPMorgan
GPS Gap
$26.87 /

+0.81 (+3.11%)

GPS Gap
$26.87 /

+0.81 (+3.11%)

GPS Gap
$26.87 /

+0.81 (+3.11%)

GPS Gap
$26.87 /

+0.81 (+3.11%)

Hot Stocks
BAE Systems awarded $197.45M Navy contract » 17:22
11/24/20
11/24
17:22
11/24/20
17:22
BAESY

BAE Systems

$0.00 /

+ (+0.00%)

BAE Systems was awarded a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BAESY BAE Systems
$0.00 /

+ (+0.00%)

BAESY BAE Systems
$0.00 /

+ (+0.00%)

12:35 Today Barclays
BAE Systems price target lowered to 635 GBp from 760 GBp at Barclays
11/23/20 Deutsche Bank
BAE Systems price target raised to 685 GBp from 675 GBp at Deutsche Bank
11/23/20 Morgan Stanley
BAE Systems price target raised to 630 GBp from 625 GBp at Morgan Stanley
11/13/20 JPMorgan
BAE Systems price target raised to 620 GBp from 615 GBp at JPMorgan
BAESY BAE Systems
$0.00 /

+ (+0.00%)

Recommendations
Verra Mobility price target raised to $15 from $13 at BTIG » 17:18
11/24/20
11/24
17:18
11/24/20
17:18
VRRM

Verra Mobility

$12.93 /

+0.18 (+1.41%)

BTIG analyst Mark Palmer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRRM Verra Mobility
$12.93 /

+0.18 (+1.41%)

VRRM Verra Mobility
$12.93 /

+0.18 (+1.41%)

11/23/20 Deutsche Bank
Verra Mobility price target raised to $13 from $12 at Deutsche Bank
06/12/20
Fly Intel: Top five analyst initiations
06/12/20 Northcoast
Verra Mobility initiated with a Buy at Northcoast
04/29/20 Credit Suisse
Verra Mobility price target lowered to $10.50 from $17 at Credit Suisse
VRRM Verra Mobility
$12.93 /

+0.18 (+1.41%)

Syndicate
MoSys files $25M mixed securities shelf  17:13
11/24/20
11/24
17:13
11/24/20
17:13
MOSY

MoSys

$1.54 /

-0.05 (-3.14%)

 
Syndicate
vTv Therapeutics files to sell 5.33M shares of Class A common stock for holders  17:10
11/24/20
11/24
17:10
11/24/20
17:10
VTVT

vTv Therapeutics

$1.85 /

-0.05 (-2.63%)

 
ShowHide Related Items >><<
VTVT vTv Therapeutics
$1.85 /

-0.05 (-2.63%)

VTVT vTv Therapeutics
$1.85 /

-0.05 (-2.63%)

02/10/20 H.C. Wainwright
vTv Therapeutics price target raised to $6 from $5 at H.C. Wainwright
VTVT vTv Therapeutics
$1.85 /

-0.05 (-2.63%)

Earnings
Nordstrom sees Q4 sales down in the low 20% range, consensus $4.01B » 17:08
11/24/20
11/24
17:08
11/24/20
17:08
JWN

Nordstrom

$24.65 /

+1.23 (+5.25%)

Says sales guidance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JWN Nordstrom
$24.65 /

+1.23 (+5.25%)

JWN Nordstrom
$24.65 /

+1.23 (+5.25%)

11/09/20 Telsey Advisory
Nordstrom upgraded to Outperform from Market Perform at Telsey Advisory
08/26/20 Citi
Nordstrom price target lowered to $17 from $19 at Citi
08/19/20 KeyBanc
Nordstrom price target lowered to $30 from $48 at KeyBanc
08/14/20 Wedbush
Wedbush cautious on Nordstrom into upcoming Q2 earnings
JWN Nordstrom
$24.65 /

+1.23 (+5.25%)

JWN Nordstrom
$24.65 /

+1.23 (+5.25%)

JWN Nordstrom
$24.65 /

+1.23 (+5.25%)

JWN Nordstrom
$24.65 /

+1.23 (+5.25%)

Hot Stocks
Alexco Resource announces initial production at Keno Hill District Mill » 17:05
11/24/20
11/24
17:05
11/24/20
17:05
AXU

Alexco Resource

$2.39 /

-0.02 (-0.83%)

Alexco Resource announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXU Alexco Resource
$2.39 /

-0.02 (-0.83%)

  • 25
    Mar
AXU Alexco Resource
$2.39 /

-0.02 (-0.83%)

Syndicate
EVO Payments 4.5M share Spot Secondary; price range $25.95-$26.50 » 17:03
11/24/20
11/24
17:03
11/24/20
17:03
EVOP

EVO Payments

$27.00 /

+0.58 (+2.20%)

JPMorgan is acting as…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVOP EVO Payments
$27.00 /

+0.58 (+2.20%)

08/17/20 JPMorgan
EVO Payments price target raised to $33 from $27 at JPMorgan
07/14/20 Goldman Sachs
EVO Payments initiated with a Neutral at Goldman Sachs
06/05/20 Compass Point
EVO Payments price target raised to $22 from $16 at Compass Point
05/11/20 SunTrust
EVO Payments price target raised to $26 from $17 at SunTrust
EVOP EVO Payments
$27.00 /

+0.58 (+2.20%)

  • 05
    Dec
EVOP EVO Payments
$27.00 /

+0.58 (+2.20%)

Hot Stocks
Yatra regains compliance with Nasdaq minimum bid price requirement » 17:03
11/24/20
11/24
17:03
11/24/20
17:03
YTRA

Yatra

$1.60 /

-0.01 (-0.62%)

Yatra Online announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
YTRA Yatra
$1.60 /

-0.01 (-0.62%)

  • 19
    Jun
YTRA Yatra
$1.60 /

-0.01 (-0.62%)

Hot Stocks
CoreLogic board 'fully supportive' of 'robust' sale process » 17:02
11/24/20
11/24
17:02
11/24/20
17:02
CLGX

CoreLogic

$77.28 /

-0.98 (-1.25%)

, CNNE

Cannae Holdings

$39.55 /

-0.19 (-0.48%)

CoreLogic (CLGX) issued a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLGX CoreLogic
$77.28 /

-0.98 (-1.25%)

CNNE Cannae Holdings
$39.55 /

-0.19 (-0.48%)

CLGX CoreLogic
$77.28 /

-0.98 (-1.25%)

10/28/20 Truist
CoreLogic could be sold for 'meaningfully more' than $80 per share, says Truist
09/22/20 Truist
CoreLogic increasingly likely to see other financial suitors, says Truist
07/24/20
Fly Intel: Top five analyst downgrades
07/24/20 Stephens
Stephens sees limited further upside for CoreLogic shares, cuts to Equal Weight
CNNE Cannae Holdings
$39.55 /

-0.19 (-0.48%)

11/19/20 Oppenheimer
Cannae Holdings initiated with an Outperform at Oppenheimer
09/22/20 Truist
CoreLogic increasingly likely to see other financial suitors, says Truist
06/26/20 SunTrust
CoreLogic upgraded to Buy from Hold at SunTrust
05/14/20 Stephens
Cannae Holdings price target raised to $43 from $40 at Stephens
CLGX CoreLogic
$77.28 /

-0.98 (-1.25%)

  • 11
    Jun
  • 04
    Dec
CLGX CoreLogic
$77.28 /

-0.98 (-1.25%)

CNNE Cannae Holdings
$39.55 /

-0.19 (-0.48%)

CLGX CoreLogic
$77.28 /

-0.98 (-1.25%)

CNNE Cannae Holdings
$39.55 /

-0.19 (-0.48%)

Hot Stocks
FDA says Reata's omaveloxolone results do not strengthen Part 2 results » 17:01
11/24/20
11/24
17:01
11/24/20
17:01
RETA

Reata Pharmaceuticals

$164.07 /

-0.71 (-0.43%)

Reata Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RETA Reata Pharmaceuticals
$164.07 /

-0.71 (-0.43%)

RETA Reata Pharmaceuticals
$164.07 /

-0.71 (-0.43%)

11/10/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $220 from $169 at Cantor Fitzgerald
11/10/20 Citi
Reata Pharmaceuticals price target raised to $260 from $244 at Citi
08/11/20 Cantor Fitzgerald
Reata Pharmaceuticals price target lowered to $169 from $275 at Cantor Fitzgerald
08/11/20 Citi
Reata Pharmaceuticals price target lowered to $244 from $254 at Citi
RETA Reata Pharmaceuticals
$164.07 /

-0.71 (-0.43%)

RETA Reata Pharmaceuticals
$164.07 /

-0.71 (-0.43%)

Upgrade
Unibail-Rodamco-Westfield upgraded to Neutral from Sell at Goldman Sachs » 17:00
11/24/20
11/24
17:00
11/24/20
17:00
UNBLF

Unibail-Rodamco-Westfield

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UNBLF Unibail-Rodamco-Westfield
$0.00 /

+ (+0.00%)

UNBLF Unibail-Rodamco-Westfield
$0.00 /

+ (+0.00%)

11/23/20 JPMorgan
Unibail-Rodamco-Westfield resumed with an Underweight at JPMorgan
11/20/20 RBC Capital
Unibail-Rodamco-Westfield price target raised to EUR 75 at RBC Capital
10/30/20 Citi
Unibail-Rodamco-Westfield price target lowered to EUR 18.90 at Citi
10/22/20 UBS
Unibail-Rodamco-Westfield price target lowered to EUR 30 from EUR 50 at UBS
Earnings
VMware sees FY22 revenue up high single digits, consensus $12.82B » 16:58
11/24/20
11/24
16:58
11/24/20
16:58
VMW

VMware

$150.50 /

+1.72 (+1.16%)

Sees FY22 operating…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VMW VMware
$150.50 /

+1.72 (+1.16%)

VMW VMware
$150.50 /

+1.72 (+1.16%)

10/23/20 Morgan Stanley
Citrix downgraded to Equal Weight on slower cloud progress at Morgan Stanley
10/20/20 KeyBanc
VMware price target raised to $180 from $170 at KeyBanc
10/15/20 JPMorgan
Dell Technologies price target raised to $80 from $70 at JPMorgan
10/13/20 UBS
VMware initiated with a Neutral at UBS
VMW VMware
$150.50 /

+1.72 (+1.16%)

VMW VMware
$150.50 /

+1.72 (+1.16%)

VMW VMware
$150.50 /

+1.72 (+1.16%)

VMW VMware
$150.50 /

+1.72 (+1.16%)

Initiation
Atea Pharmaceuticals initiated with an Outperform at Evercore ISI » 16:58
11/24/20
11/24
16:58
11/24/20
16:58
AVIR

Atea Pharmaceuticals

$34.00 /

+0.38 (+1.13%)

, GILD

Gilead

$60.25 /

+0.37 (+0.62%)

Evercore ISI analyst Umer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVIR Atea Pharmaceuticals
$34.00 /

+0.38 (+1.13%)

GILD Gilead
$60.25 /

+0.37 (+0.62%)

AVIR Atea Pharmaceuticals
$34.00 /

+0.38 (+1.13%)

08:02 Today Morgan Stanley
Atea Pharmaceuticals initiated with an Overweight at Morgan Stanley
08:00 Today JPMorgan
Atea Pharmaceuticals initiated with an Overweight at JPMorgan
06:59 Today William Blair
William Blair starts Atea Pharmaceuticals with Outperform, $60 fair value
06:17 Today William Blair
Atea Pharmaceuticals initiated with an Outperform at William Blair
GILD Gilead
$60.25 /

+0.37 (+0.62%)

06:37 Today Berenberg
Arcus Biosciences initiated with a Buy at Berenberg
11/20/20 Raymond James
Use of Gilead's remdesivir likely to skew to U.S. into Q1, says Raymond James
11/03/20
Fly Intel: Top five analyst initiations
11/03/20 Morgan Stanley
Gilead resumed with an Equal Weight at Morgan Stanley
GILD Gilead
$60.25 /

+0.37 (+0.62%)

  • 30
    Oct
GILD Gilead
$60.25 /

+0.37 (+0.62%)

AVIR Atea Pharmaceuticals
$34.00 /

+0.38 (+1.13%)

GILD Gilead
$60.25 /

+0.37 (+0.62%)

GILD Gilead
$60.25 /

+0.37 (+0.62%)

Earnings
VMware sees FY21 EPS $7.03, consensus $6.66 » 16:57
11/24/20
11/24
16:57
11/24/20
16:57
VMW

VMware

$150.50 /

+1.72 (+1.16%)

Sees FY21 revenue $11.7B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VMW VMware
$150.50 /

+1.72 (+1.16%)

VMW VMware
$150.50 /

+1.72 (+1.16%)

10/23/20 Morgan Stanley
Citrix downgraded to Equal Weight on slower cloud progress at Morgan Stanley
10/20/20 KeyBanc
VMware price target raised to $180 from $170 at KeyBanc
10/15/20 JPMorgan
Dell Technologies price target raised to $80 from $70 at JPMorgan
10/13/20 UBS
VMware initiated with a Neutral at UBS
VMW VMware
$150.50 /

+1.72 (+1.16%)

VMW VMware
$150.50 /

+1.72 (+1.16%)

VMW VMware
$150.50 /

+1.72 (+1.16%)

VMW VMware
$150.50 /

+1.72 (+1.16%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.